Skip to main content

BRIEF-Anavex signs material transfer agreement with Biogen

* Signed material transfer agreement with Biogen under which Biogen will test Anavex's lead drug candidate, Anavex 2-73 Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.